Want to see GB:EMVC full AI Analyst Report?
EMVC Stock Chart & Stats
51.00 p
0.00 p(0.00%)
At close: 4:00 PM EDT
51.00 p
0.00 p(0.00%)
Day’s Range― - ―
52-Week Range43.00 p - 62.00 p
Previous CloseN/A
Volume9.91K
Average Volume (3M)24.81K
Market Cap
£12.59M
Enterprise Value14.68M
Total Cash (Recent Filing)£656.00K
Total Debt (Recent Filing)£810.00K
Price to Earnings (P/E)0.7
Beta0.63
Next Earnings
Mar 31, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.69
Shares Outstanding27,967,531
10 Day Avg. Volume30,753
30 Day Avg. Volume24,808
Financial Highlights & Ratios
PEG Ratio5.74
Price to Book (P/B)1.04
Price to Sales (P/S)5.52
P/FCF Ratio-12.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.84
Revenue Forecast (FY)£3.23M
Bulls Say, Bears Say
Bulls Say
Improving Revenue GrowthSustained revenue expansion indicates increasing activity across the portfolio and improving commercialization progress. Although the base remains small, continued growth can strengthen operating leverage and create a clearer path toward covering the platform’s fixed cost structure.
Strong Gross MarginsHigh gross margins suggest that successful portfolio commercialization could retain substantial economic value after direct costs. This provides a favorable foundation for future operating leverage, provided revenue scales enough to offset the company’s currently high overhead and investment spending.
Supportive Balance SheetA sizable equity base relative to debt gives NetScientific greater financial resilience than a highly leveraged investment platform. This supports continued portfolio development and provides more flexibility to absorb volatility while the company works toward improved cash generation.
Bears Say
Persistent Operating LossesDeep operating losses show that the current platform cost base remains too large for the revenue generated by the portfolio. Without further scaling or cost reduction, revenue growth may not translate into durable earnings, limiting internal funding capacity and financial consistency.
Ongoing Cash BurnPersistent negative operating and free cash flow means the business is not yet self-funding its activities. Continued reliance on external capital or existing balance-sheet resources can constrain portfolio investment, increase execution risk, and weaken flexibility if cash needs remain elevated.
Rising Debt And Falling EquityThe combination of higher debt and a declining equity base increases financial risk even though leverage remains relatively modest. If losses and cash burn persist, further balance-sheet deterioration could reduce funding flexibility and make portfolio support more dependent on new capital.
NetScientific News
EMVC FAQ
What was NetScientific PLC’s price range in the past 12 months?
NetScientific PLC lowest share price was 43.00 p and its highest was 62.00 p in the past 12 months.
What is NetScientific PLC’s market cap?
NetScientific PLC’s market cap is £12.59M.
When is NetScientific PLC’s upcoming earnings report date?
NetScientific PLC’s upcoming earnings report date is Mar 31, 2027 which is in 171 days.
How were NetScientific PLC’s earnings last quarter?
NetScientific PLC released its earnings results on Sep 24, 2026. The company reported 0.649 p earnings per share for the quarter.
Is NetScientific PLC overvalued?
According to Wall Street analysts NetScientific PLC’s price is currently Overvalued.
Does NetScientific PLC pay dividends?
NetScientific PLC does not currently pay dividends.
What is NetScientific PLC’s EPS estimate?
NetScientific PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NetScientific PLC have?
NetScientific PLC has 27,967,531 shares outstanding.
What happened to NetScientific PLC’s price movement after its last earnings report?
NetScientific PLC reported an EPS of 0.649 p in its last earnings report. Following the earnings report the stock price went down -3.093%.
Which hedge fund is a major shareholder of NetScientific PLC?
Currently, no hedge funds are holding shares in GB:EMVC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NetScientific PLC
EMV Capital plc operates as a venture capital firm, primarily targeting investments across the full spectrum of early-stage funding, from seed rounds through to mid-stage and growth capital. Its investment mandate spans diverse high-growth sectors, including sustainability, life science, technology, transformative biomedical, deep tech, semiconductors, industrials, robotics, and artificial intelligence. The firm also places a strong emphasis on healthcare technologies, particularly digital health, diagnostics, and therapeutics, with a specific focus on ventures that enhance the lives and health outcomes of individuals battling chronic illnesses. Within digital health, core interests lie in data analytics, advanced wearable devices, and other related technologies. Geographically, EMV Capital seeks opportunities within developed European markets, including its home base in the United Kingdom, as well as the United States. While typical investment sizes reach up to £15 million (approximately $20.32 million), the firm retains the flexibility to commit larger sums. A strategic preference is to secure a controlling stake in key subsidiary companies, with investments primarily executed via its balance sheet. Established in 2008, EMV Capital plc operates from its headquarters in London, UK, with an additional presence in Beaconsfield.